Clinical Trial Update: Long-term Open-label Study of Botulinumtoxin Type A to Treat Spasticity of Leg(s) or Leg(s) and Arm in Cerebral Palsy [Phase 3]

View source ↗

Summary

This clinical trial update reports the completion and posting of results for a long-term open-label Phase 3 study of botulinum toxin type A for leg spasticity (…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Palsy

Drugs mentioned

• Botulinumtoxin Type A (botulinum toxin type A)

Snippet

Sponsor: Merz Pharmaceuticals GmbH | Conditions: Lower Limb and Combined Lower Limb and Upper Limb Spasticity Due to Cerebral Palsy | Phase 3 | Status: COMPLETED | Results posted: 2017-10-27